Skip to main content
Erschienen in: Journal of Neuro-Oncology 1/2011

01.08.2011 | Laboratory Investigation - Human/Animal Tissue

Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: implications for chemotherapy

verfasst von: Shailendra Joshi, Aysegul Ergin, Mei Wang, Roberto Reif, Jane Zhang, Jeffrey N. Bruce, Irving J. Bigio

Erschienen in: Journal of Neuro-Oncology | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

The novel ability to quantify drug and tracer concentrations in vivo by optical means leads to the possibility of detecting and quantifying blood brain barrier (BBB) disruption in real-time by monitoring concentrations of chromophores such as Evan’s Blue. In this study, experiments were conducted to assess the disruption of the BBB, by intraarterial injection of mannitol, in New Zealand white rabbits. Surgical preparation included: tracheotomy for mechanical ventilation, femoral and selective internal carotid artery (ICA) catheterizations, skull screws for monitoring electrocerebral activity, bilateral placement of laser Doppler probes and a small craniotomy for the placement of a fiber optic probe to determine tissue Evan’s Blue dye concentrations. Evans Blue (6.5 mg/kg) was injected intravenously (IV) just before BBB disruption with intracarotid mannitol (25%, 8 ml/40 s). Brain tissue concentrations of the dye in mannitol-treated and control animals were monitored using the method of optical pharmacokinetics (OP) during the subsequent 60 min. Hemodynamic parameters, heart rate, blood pressure, and EKG remained stable throughout the experiments in both the control and the mannitol-treated group. Brain tissue concentrations of Evan’s Blue and the brain:plasma Evan’s Blue partition coefficient progressively increased during the period of observation. A wide variation in brain tissue Evan’s Blue concentrations was observed in the mannitol group. The experiments demonstrate the feasibility of measuring tissue concentrations of Evan’s Blue without invading the brain parenchyma, and in real-time. The data suggest that there are significant variations in the degree and duration of BBB disruption induced with intraarterial mannitol. The ability to optically monitor the BBB disruption in real-time could provide a feedback control for hypertonic disruption and/or facilitate dosage control for chemotherapeutic drugs that require such disruption.
Literatur
1.
Zurück zum Zitat Neuwelt E, Abbott NJ, Abrey L et al (2008) Strategies to advance translational research into brain barriers. Lancet Neurol 7:84–96PubMedCrossRef Neuwelt E, Abbott NJ, Abrey L et al (2008) Strategies to advance translational research into brain barriers. Lancet Neurol 7:84–96PubMedCrossRef
2.
Zurück zum Zitat Nagaraja TN, Keenan KA, Fenstermacher JD, Knight RA (2008) Acute leakage patterns of fluorescent plasma flow markers after transient focal cerebral ischemia suggest large openings in blood–brain barrier. Microcirculation 15:1–14PubMedCrossRef Nagaraja TN, Keenan KA, Fenstermacher JD, Knight RA (2008) Acute leakage patterns of fluorescent plasma flow markers after transient focal cerebral ischemia suggest large openings in blood–brain barrier. Microcirculation 15:1–14PubMedCrossRef
3.
Zurück zum Zitat Black KL, Cloughesy T, Huang SC et al (1997) Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas. J Neurosurg 86:603–609PubMedCrossRef Black KL, Cloughesy T, Huang SC et al (1997) Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas. J Neurosurg 86:603–609PubMedCrossRef
4.
Zurück zum Zitat Bhattacharjee AK, Kondoh T, Nagashima T et al (2001) Quantitative analysis of papaverine-mediated blood–brain barrier disruption in rats. Biochem Biophys Res Commun 289:548–552PubMedCrossRef Bhattacharjee AK, Kondoh T, Nagashima T et al (2001) Quantitative analysis of papaverine-mediated blood–brain barrier disruption in rats. Biochem Biophys Res Commun 289:548–552PubMedCrossRef
5.
Zurück zum Zitat Cloughesy TF, Black KL, Gobin YP et al (1999) Intra-arterial Cereport (RMP-7) and carboplatin: a dose escalation study for recurrent malignant gliomas. Neurosurgery 44:270–278 (discussion 278–279)PubMedCrossRef Cloughesy TF, Black KL, Gobin YP et al (1999) Intra-arterial Cereport (RMP-7) and carboplatin: a dose escalation study for recurrent malignant gliomas. Neurosurgery 44:270–278 (discussion 278–279)PubMedCrossRef
6.
Zurück zum Zitat Lee HJ, Zhang Y, Pardridge WM (2002) Blood–brain barrier disruption following the internal carotid arterial perfusion of alkyl glycerols. J Drug Target 10:463–467PubMedCrossRef Lee HJ, Zhang Y, Pardridge WM (2002) Blood–brain barrier disruption following the internal carotid arterial perfusion of alkyl glycerols. J Drug Target 10:463–467PubMedCrossRef
7.
Zurück zum Zitat Neufeld GR (1971) Computation of transit time distributions using sampled data Laplace transforms. J Appl Physiol 31:148–153PubMed Neufeld GR (1971) Computation of transit time distributions using sampled data Laplace transforms. J Appl Physiol 31:148–153PubMed
8.
Zurück zum Zitat Zylber-Katz E, Gomori JM, Schwartz A et al (2000) Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood–brain barrier disruption in patients with brain lymphoma. Clin Pharmacol Ther 67:631–641PubMedCrossRef Zylber-Katz E, Gomori JM, Schwartz A et al (2000) Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood–brain barrier disruption in patients with brain lymphoma. Clin Pharmacol Ther 67:631–641PubMedCrossRef
9.
Zurück zum Zitat Doolittle ND, Miner ME, Hall WA et al (2000) Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood–brain barrier for the treatment of patients with malignant brain tumors. Cancer 88:637–647PubMedCrossRef Doolittle ND, Miner ME, Hall WA et al (2000) Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood–brain barrier for the treatment of patients with malignant brain tumors. Cancer 88:637–647PubMedCrossRef
10.
Zurück zum Zitat Bellavance MA, Blanchette M, Fortin D (2008) Recent advances in blood-brain barrier disruption as a CNS delivery strategy. AAPS J 10:166–177PubMedCrossRef Bellavance MA, Blanchette M, Fortin D (2008) Recent advances in blood-brain barrier disruption as a CNS delivery strategy. AAPS J 10:166–177PubMedCrossRef
11.
Zurück zum Zitat Marchi N, Angelov L, Masaryk T et al (2007) Seizure-promoting effect of blood–brain barrier disruption. Epilepsia 48:732–742PubMedCrossRef Marchi N, Angelov L, Masaryk T et al (2007) Seizure-promoting effect of blood–brain barrier disruption. Epilepsia 48:732–742PubMedCrossRef
12.
Zurück zum Zitat Elkassabany NM, Bhatia J, Deogaonkar A et al (2008) Perioperative complications of blood brain barrier disruption under general anesthesia: a retrospective review. J Neurosurg Anesthesiol 20:45–48PubMedCrossRef Elkassabany NM, Bhatia J, Deogaonkar A et al (2008) Perioperative complications of blood brain barrier disruption under general anesthesia: a retrospective review. J Neurosurg Anesthesiol 20:45–48PubMedCrossRef
13.
Zurück zum Zitat Remsen LG, Pagel MA, McCormick CI et al (1999) The influence of anesthetic choice, PaCO2, and other factors on osmotic blood-brain barrier disruption in rats with brain tumor xenografts. Anesth Analg 88:559–567PubMed Remsen LG, Pagel MA, McCormick CI et al (1999) The influence of anesthetic choice, PaCO2, and other factors on osmotic blood-brain barrier disruption in rats with brain tumor xenografts. Anesth Analg 88:559–567PubMed
14.
Zurück zum Zitat Mourant JR, Johnson TM, Los G, Bigio IJ (1999) Non-invasive measurement of chemotherapy drug concentrations in tissue: preliminary demonstrations of in vivo measurements. Phys Med Biol 44:1397–1417PubMedCrossRef Mourant JR, Johnson TM, Los G, Bigio IJ (1999) Non-invasive measurement of chemotherapy drug concentrations in tissue: preliminary demonstrations of in vivo measurements. Phys Med Biol 44:1397–1417PubMedCrossRef
15.
Zurück zum Zitat Bigio IJ, Mourant JR (1997) Ultraviolet and visible spectroscopies for tissue diagnostics: fluorescence spectroscopy and elastic-scattering spectroscopy. Phys Med Biol 42:803–814PubMedCrossRef Bigio IJ, Mourant JR (1997) Ultraviolet and visible spectroscopies for tissue diagnostics: fluorescence spectroscopy and elastic-scattering spectroscopy. Phys Med Biol 42:803–814PubMedCrossRef
16.
Zurück zum Zitat Bigio IJ, Mourant JR, Los G (1999) Noninvasive, in situ measurement of drug concentrations in tissue using optical spectroscopy. J Gravit Physiol 6:P173–P175PubMed Bigio IJ, Mourant JR, Los G (1999) Noninvasive, in situ measurement of drug concentrations in tissue using optical spectroscopy. J Gravit Physiol 6:P173–P175PubMed
17.
Zurück zum Zitat Reif R, Wang M, Joshi S et al (2007) Optical method for real-time monitoring of drug concentrations facilitates the development of novel methods for drug delivery to brain tissue. J Biomed Opt 12:034036PubMedCrossRef Reif R, Wang M, Joshi S et al (2007) Optical method for real-time monitoring of drug concentrations facilitates the development of novel methods for drug delivery to brain tissue. J Biomed Opt 12:034036PubMedCrossRef
18.
Zurück zum Zitat Kanick SC, Eiseman JL, Joseph E et al (2007) Noninvasive and nondestructive optical spectroscopic measurement of motexafin gadolinium in mouse tissues: comparison to high-performance liquid chromatography. J Photochem Photobiol B 88:90–104PubMedCrossRef Kanick SC, Eiseman JL, Joseph E et al (2007) Noninvasive and nondestructive optical spectroscopic measurement of motexafin gadolinium in mouse tissues: comparison to high-performance liquid chromatography. J Photochem Photobiol B 88:90–104PubMedCrossRef
19.
Zurück zum Zitat Wang M, Etu J, Joshi S (2007) Enhanced disruption of the blood brain barrier by intracarotid mannitol injection during transient cerebral hypoperfusion in rabbits. J Neurosurg Anesthesiol 19:249–256PubMedCrossRef Wang M, Etu J, Joshi S (2007) Enhanced disruption of the blood brain barrier by intracarotid mannitol injection during transient cerebral hypoperfusion in rabbits. J Neurosurg Anesthesiol 19:249–256PubMedCrossRef
20.
Zurück zum Zitat Joshi S, Wang M, Hartl R (2004) Retinal discoloration test. J Cereb Blood Flow Metab 24:305–308PubMedCrossRef Joshi S, Wang M, Hartl R (2004) Retinal discoloration test. J Cereb Blood Flow Metab 24:305–308PubMedCrossRef
21.
Zurück zum Zitat Joshi S, Wang M, Nishanian EV, Emerson RG (2004) Electrocerebral silence by intracarotid anesthetics does not affect early hyperemia after transient cerebral ischemia in rabbits. Anesth Analg 98:1454–1459 (table of contents)PubMedCrossRef Joshi S, Wang M, Nishanian EV, Emerson RG (2004) Electrocerebral silence by intracarotid anesthetics does not affect early hyperemia after transient cerebral ischemia in rabbits. Anesth Analg 98:1454–1459 (table of contents)PubMedCrossRef
22.
Zurück zum Zitat Lee JS, Hamilton MG, Zabramski JM (1994) Variations in the anatomy of the rabbit cervical carotid artery. Stroke 25:501–503PubMedCrossRef Lee JS, Hamilton MG, Zabramski JM (1994) Variations in the anatomy of the rabbit cervical carotid artery. Stroke 25:501–503PubMedCrossRef
23.
Zurück zum Zitat Perkins BA, Strausbaugh LJ (1983) Effect of mannitol infusions into the internal carotid artery on entry of two antibiotics into the cerebrospinal fluid and brains of normal rabbits. Antimicrob Agents Chemother 24:339–342PubMed Perkins BA, Strausbaugh LJ (1983) Effect of mannitol infusions into the internal carotid artery on entry of two antibiotics into the cerebrospinal fluid and brains of normal rabbits. Antimicrob Agents Chemother 24:339–342PubMed
24.
Zurück zum Zitat Wang M, Joshi S (2002) Comparison of intravenous and intracarotid propofol for electrical silence on EEG. J Neurosurg Anesthesiol 14:333CrossRef Wang M, Joshi S (2002) Comparison of intravenous and intracarotid propofol for electrical silence on EEG. J Neurosurg Anesthesiol 14:333CrossRef
25.
Zurück zum Zitat Strausbaugh LJ (1987) Intracarotid infusions of protamine sulfate disrupt the blood–brain barrier of rabbits. Brain Res 409:221–226PubMedCrossRef Strausbaugh LJ (1987) Intracarotid infusions of protamine sulfate disrupt the blood–brain barrier of rabbits. Brain Res 409:221–226PubMedCrossRef
26.
Zurück zum Zitat Chen X, Gawryluk JW, Wagener JF et al (2008) Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer’s disease. J Neuroinflamm 5:12CrossRef Chen X, Gawryluk JW, Wagener JF et al (2008) Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer’s disease. J Neuroinflamm 5:12CrossRef
27.
Zurück zum Zitat Provenzale JM, Mukundan S, Dewhirst M (2005) The role of blood–brain barrier permeability in brain tumor imaging and therapeutics. AJR Am J Roentgenol 185:763–767PubMedCrossRef Provenzale JM, Mukundan S, Dewhirst M (2005) The role of blood–brain barrier permeability in brain tumor imaging and therapeutics. AJR Am J Roentgenol 185:763–767PubMedCrossRef
28.
Zurück zum Zitat Chi OZ, Liu X, Weiss HR (2001) Effects of mild hypothermia on blood–brain barrier disruption during isoflurane or pentobarbital anesthesia. Anesthesiology 95:933–938PubMedCrossRef Chi OZ, Liu X, Weiss HR (2001) Effects of mild hypothermia on blood–brain barrier disruption during isoflurane or pentobarbital anesthesia. Anesthesiology 95:933–938PubMedCrossRef
29.
Zurück zum Zitat Gumerlock MK, Neuwelt EA (1990) The effects of anesthesia on osmotic blood–brain barrier disruption. Neurosurgery 26:268–277PubMedCrossRef Gumerlock MK, Neuwelt EA (1990) The effects of anesthesia on osmotic blood–brain barrier disruption. Neurosurgery 26:268–277PubMedCrossRef
30.
Zurück zum Zitat Chi OZ, Chun TW, Liu X, Weiss HR (1998) The effects of pentobarbital on blood–brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats. Anesth Analg 86:1230–1235PubMed Chi OZ, Chun TW, Liu X, Weiss HR (1998) The effects of pentobarbital on blood–brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats. Anesth Analg 86:1230–1235PubMed
31.
Zurück zum Zitat Bullard DE, Bourdon M, Bigner DD (1984) Comparison of various methods for delivering radiolabeled monoclonal antibody to normal rat brain. J Neurosurg 61:901–911PubMedCrossRef Bullard DE, Bourdon M, Bigner DD (1984) Comparison of various methods for delivering radiolabeled monoclonal antibody to normal rat brain. J Neurosurg 61:901–911PubMedCrossRef
32.
Zurück zum Zitat Mychaskiw G II, Badr AE, Tibbs R et al (2000) Optison (FS069) disrupts the blood-brain barrier in rats. Anesth Analg 91:798–803PubMedCrossRef Mychaskiw G II, Badr AE, Tibbs R et al (2000) Optison (FS069) disrupts the blood-brain barrier in rats. Anesth Analg 91:798–803PubMedCrossRef
33.
Zurück zum Zitat Wolf M, Ferrari M, Quaresima V (2007) Progress of near-infrared spectroscopy and topography for brain and muscle clinical applications. J Biomed Opt 12:062104PubMedCrossRef Wolf M, Ferrari M, Quaresima V (2007) Progress of near-infrared spectroscopy and topography for brain and muscle clinical applications. J Biomed Opt 12:062104PubMedCrossRef
34.
Zurück zum Zitat Ueno M (2007) Molecular anatomy of the brain endothelial barrier: an overview of the distributional features. Curr Med Chem 14:1199–1206PubMedCrossRef Ueno M (2007) Molecular anatomy of the brain endothelial barrier: an overview of the distributional features. Curr Med Chem 14:1199–1206PubMedCrossRef
35.
Zurück zum Zitat Riina HA, Fraser JF, Fralin S et al (2009) Superselective intraarterial cerebral infusion of bevacizumab: a revival of interventional neuro-oncology for malignant glioma. J Exp Ther Oncol 8:145–150PubMed Riina HA, Fraser JF, Fralin S et al (2009) Superselective intraarterial cerebral infusion of bevacizumab: a revival of interventional neuro-oncology for malignant glioma. J Exp Ther Oncol 8:145–150PubMed
36.
Zurück zum Zitat Baumbach GL, Mayhan WG, Heistad DD (1986) Protection of the blood–brain barrier by hypercapnia during acute hypertension. Am J Physiol 251:H282–H287PubMed Baumbach GL, Mayhan WG, Heistad DD (1986) Protection of the blood–brain barrier by hypercapnia during acute hypertension. Am J Physiol 251:H282–H287PubMed
37.
Zurück zum Zitat Ballabh P, Braun A, Nedergaard M (2004) The blood–brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 16:1–13PubMedCrossRef Ballabh P, Braun A, Nedergaard M (2004) The blood–brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 16:1–13PubMedCrossRef
38.
Zurück zum Zitat Al-Sarraf H, Ghaaedi F, Redzic Z (2007) Time course of hyperosmolar opening of the blood–brain and blood–CSF barriers in spontaneously hypertensive rats. J Vasc Res 44:99–109PubMedCrossRef Al-Sarraf H, Ghaaedi F, Redzic Z (2007) Time course of hyperosmolar opening of the blood–brain and blood–CSF barriers in spontaneously hypertensive rats. J Vasc Res 44:99–109PubMedCrossRef
39.
Zurück zum Zitat van Horssen J, Brink BP, de Vries HE et al (2007) The blood–brain barrier in cortical multiple sclerosis lesions. J Neuropathol Exp Neurol 66:321–328PubMedCrossRef van Horssen J, Brink BP, de Vries HE et al (2007) The blood–brain barrier in cortical multiple sclerosis lesions. J Neuropathol Exp Neurol 66:321–328PubMedCrossRef
40.
Zurück zum Zitat Soon D, Tozer DJ, Altmann DR et al (2007) Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes. Mult Scler 13:884–894PubMedCrossRef Soon D, Tozer DJ, Altmann DR et al (2007) Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes. Mult Scler 13:884–894PubMedCrossRef
41.
Zurück zum Zitat Ruda R, Trevisan E, Soffietti R (2010) Epilepsy and brain tumors. Curr Opin Oncol 22(6):611–620 Ruda R, Trevisan E, Soffietti R (2010) Epilepsy and brain tumors. Curr Opin Oncol 22(6):611–620
42.
Zurück zum Zitat Kalayci R, Kaya M, Ahishali B et al (2006) Long-term L-NAME treatment potentiates the blood–brain barrier disruption during pentylenetetrazole-induced seizures in rats. Life Sci 79:16–20PubMedCrossRef Kalayci R, Kaya M, Ahishali B et al (2006) Long-term L-NAME treatment potentiates the blood–brain barrier disruption during pentylenetetrazole-induced seizures in rats. Life Sci 79:16–20PubMedCrossRef
43.
Zurück zum Zitat Brown RC, Davis TP (2002) Calcium modulation of adherens and tight junction function: a potential mechanism for blood–brain barrier disruption after stroke. Stroke 33:1706–1711PubMedCrossRef Brown RC, Davis TP (2002) Calcium modulation of adherens and tight junction function: a potential mechanism for blood–brain barrier disruption after stroke. Stroke 33:1706–1711PubMedCrossRef
44.
Zurück zum Zitat Neuwelt EA, Barnett PA, Ramsey FL et al (1993) Dexamethasone decreases the delivery of tumor-specific monoclonal antibody to both intracerebral and subcutaneous tumor xenografts. Neurosurgery 33:478–484 (discussion 484)PubMedCrossRef Neuwelt EA, Barnett PA, Ramsey FL et al (1993) Dexamethasone decreases the delivery of tumor-specific monoclonal antibody to both intracerebral and subcutaneous tumor xenografts. Neurosurgery 33:478–484 (discussion 484)PubMedCrossRef
45.
Zurück zum Zitat Euser AG, Bullinger L, Cipolla MJ (2008) Magnesium sulphate treatment decreases blood–brain barrier permeability during acute hypertension in pregnant rats. Exp Physiol 93:254–261PubMedCrossRef Euser AG, Bullinger L, Cipolla MJ (2008) Magnesium sulphate treatment decreases blood–brain barrier permeability during acute hypertension in pregnant rats. Exp Physiol 93:254–261PubMedCrossRef
46.
Zurück zum Zitat Bhattacharjee AK, Nagashima T, Kondoh T, Tamaki N (2001) The effects of the Na(+)/Ca(++) exchange blocker on osmotic blood–brain barrier disruption. Brain Res 900:157–162PubMedCrossRef Bhattacharjee AK, Nagashima T, Kondoh T, Tamaki N (2001) The effects of the Na(+)/Ca(++) exchange blocker on osmotic blood–brain barrier disruption. Brain Res 900:157–162PubMedCrossRef
47.
Zurück zum Zitat Siegal T, Rubinstein R, Bokstein F et al (2000) In vivo assessment of the window of barrier opening after osmotic blood–brain barrier disruption in humans. J Neurosurg 92:599–605PubMedCrossRef Siegal T, Rubinstein R, Bokstein F et al (2000) In vivo assessment of the window of barrier opening after osmotic blood–brain barrier disruption in humans. J Neurosurg 92:599–605PubMedCrossRef
48.
Zurück zum Zitat Boje KM, Lakhman SS (2000) Nitric oxide redox species exert differential permeability effects on the blood–brain barrier. J Pharmacol Exp Ther 293:545–550PubMed Boje KM, Lakhman SS (2000) Nitric oxide redox species exert differential permeability effects on the blood–brain barrier. J Pharmacol Exp Ther 293:545–550PubMed
49.
Zurück zum Zitat Boje KM (1996) Inhibition of nitric oxide synthase attenuates blood–brain barrier disruption during experimental meningitis. Brain Res 720:75–83PubMedCrossRef Boje KM (1996) Inhibition of nitric oxide synthase attenuates blood–brain barrier disruption during experimental meningitis. Brain Res 720:75–83PubMedCrossRef
50.
Zurück zum Zitat Brown RC, Egleton RD, Davis TP (2004) Mannitol opening of the blood–brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albumin. Brain Res 1014:221–227PubMedCrossRef Brown RC, Egleton RD, Davis TP (2004) Mannitol opening of the blood–brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albumin. Brain Res 1014:221–227PubMedCrossRef
Metadaten
Titel
Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: implications for chemotherapy
verfasst von
Shailendra Joshi
Aysegul Ergin
Mei Wang
Roberto Reif
Jane Zhang
Jeffrey N. Bruce
Irving J. Bigio
Publikationsdatum
01.08.2011
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 1/2011
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-010-0466-4

Weitere Artikel der Ausgabe 1/2011

Journal of Neuro-Oncology 1/2011 Zur Ausgabe

Letter to the Editor

Brain tumors and driving

Clinical Study – Patient Study

Intracranial tumors in Kuwait: a 15-year survey

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.